Interpreting Amgen Sales From J&J’s PROCRIT (AMGN, JNJ)
Shares of Amgen Inc. (NASDAQ:AMGN) are under bit of pressure this morning, although not from any direct news from the company itself. Luckily for Amgen, much of the bad news ...Read Full Story »

